Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/15244
The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
Identifiers
ISSN: 2110-5820
WOS ID: 000404769700002
Scopus EID: 2-s2.0-85018503351
PMID: 28429310
Embase PUI: L615480090
Share
Statistics
Item usage statisticsMetadata
Show Dublin Core item recordAuthor
Martin-Loeches, Ignacio; Muriel-Bombin, Arturo; Ferrer, Ricard; Artigas, Antonio; Sole-Violan, Jordi; Lorente, Leonardo; Andaluz-Ojeda, David; Prina-Mello, Adriele; Herran-Monge, Ruben; Suberviola, Borja; Rodriguez-Fernandez, Ana; Merino, Pedro; Loza, Ana M.; Garcia-Olivares, Pablo; Anton, Eduardo; Tamayo, Eduardo; Trapiello, Wysali; Blanco, Jesus; Bermejo-Martin, Jesos F.; GRECIA GrpPublication date
2017-04-20Document type
research articleCitation
Martin-Loeches I, Muriel-Bombin A, Ferrer R, Artigas A, Sole-Violan J, Lorente L, et al. The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure. Ann Intensive Care. 2017 Apr 20;7:44. Epub 2017 Apr 20.Abstract
Background: Pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate the impact of endogenous immunoglobulins on the mortality risk in sepsis depending on disease severity. Methods: This was a retrospective observational study including 278 patients admitted to the ICU with sepsis fulfilling the SEPSIS-3 criteria, coming from the Spanish GRECIA and ABISS-EDUSEPSIS cohorts. Patients were distributed into two groups depending on their Sequential Organ Failure Assessment score at ICU admission (SOFA < 8, n = 122 and SOFA >= 8, n = 156), and the association between immunoglobulin levels at ICU admission with mortality was studied in each group by Kaplan-Meier and multivariate logistic regression analysis. Results: ICU/hospital mortality in the SOFA < 8 group was 14.8/23.0%, compared to 30.1/35.3% in the SOFA >= 8 group. In the group with SOFA < 8, the simultaneous presence of total IgG < 407 mg/dl, IgM < 43 mg/dl and IgA < 219 mg/dl was associated with a reduction in the survival mean time of 6.6 days in the first 28 days and was a robust predictor of mortality risk either during the acute or during the post-acute phase of the disease (OR for ICU mortality: 13.79; OR for hospital mortality: 7.98). This predictive ability remained in the absence of prior immunosuppression (OR for ICU mortality: 17.53; OR for hospital mortality: 5.63). Total IgG < 407 mg/dl or IgG1 < 332 mg/dl was also an independent predictor of ICU mortality in this group. In contrast, in the SOFA >= 8 group, we found no immunoglobulin thresholds associated with neither ICU nor hospital mortality. Conclusions: Endogenous immunoglobulin levels may have a different impact on the mortality risk of sepsis patients based on their severity. In patients with moderate organ failure, the simultaneous presence of low levels of IgG, IgA and IgM was a consistent predictor of both acute and post-acute mortalities.
Publisher version
https://dx.doi.org/10.1186/s13613-017-0268-3Keywords
ImmunoglobulinsSepsis
Severity
Survival